293 related articles for article (PubMed ID: 36127739)
1. Inhaled aviptadil for the possible treatment of COVID-19 in patients at high risk for ARDS: study protocol for a randomized, placebo-controlled, and multicenter trial.
Boesing M; Abig K; Brändle M; Brutsche M; Burri E; Frye BC; Giezendanner S; Grutters JC; Haas P; Heisler J; Jaun F; Leuppi-Taegtmeyer AB; Lüthi-Corridori G; Müller-Quernheim J; Nüesch R; Pohl W; Rassouli F; Leuppi JD
Trials; 2022 Sep; 23(1):790. PubMed ID: 36127739
[TBL] [Abstract][Full Text] [Related]
2. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
3. Effect of dexamethasone in patients with ARDS and COVID-19 - prospective, multi-centre, open-label, parallel-group, randomised controlled trial (REMED trial): A structured summary of a study protocol for a randomised controlled trial.
Maláska J; Stašek J; Duška F; Balík M; Máca J; Hruda J; Vymazal T; Klementová O; Zatloukal J; Gabrhelík T; Novotný P; Demlová R; Kubátová J; Vinklerová J; Svobodník A; Kratochvíl M; Klučka J; Gál R; Singer M;
Trials; 2021 Mar; 22(1):172. PubMed ID: 33648568
[TBL] [Abstract][Full Text] [Related]
4. Double-blind, randomized, controlled, trial to assess the efficacy of allogenic mesenchymal stromal cells in patients with acute respiratory distress syndrome due to COVID-19 (COVID-AT): A structured summary of a study protocol for a randomised controlled trial.
Payares-Herrera C; Martínez-Muñoz ME; Vallhonrat IL; de Molina RM; Torres MP; Trisan A; de Diego IS; Alonso R; Zafra R; Donaire T; Sánchez R; Rubio JJ; Duarte Palomino RF; Solá CA
Trials; 2021 Jan; 22(1):9. PubMed ID: 33407777
[TBL] [Abstract][Full Text] [Related]
5. Intravenous aviptadil and remdesivir for treatment of COVID-19-associated hypoxaemic respiratory failure in the USA (TESICO): a randomised, placebo-controlled trial.
Brown SM; Barkauskas CE; Grund B; Sharma S; Phillips AN; Leither L; Peltan ID; Lanspa M; Gilstrap DL; Mourad A; Lane K; Beitler JR; Serra AL; Garcia I; Almasri E; Fayed M; Hubel K; Harris ES; Middleton EA; Barrios MAG; Mathews KS; Goel NN; Acquah S; Mosier J; Hypes C; Salvagio Campbell E; Khan A; Hough CL; Wilson JG; Levitt JE; Duggal A; Dugar S; Goodwin AJ; Terry C; Chen P; Torbati S; Iyer N; Sandkovsky US; Johnson NJ; Robinson BRH; Matthay MA; Aggarwal NR; Douglas IS; Casey JD; Hache-Marliere M; Georges Youssef J; Nkemdirim W; Leshnower B; Awan O; Pannu S; O'Mahony DS; Manian P; Awori Hayanga JW; Wortmann GW; Tomazini BM; Miller RF; Jensen JU; Murray DD; Bickell NA; Zatakia J; Burris S; Higgs ES; Natarajan V; Dewar RL; Schechner A; Kang N; Arenas-Pinto A; Hudson F; Ginde AA; Self WH; Rogers AJ; Oldmixon CF; Morin H; Sanchez A; Weintrob AC; Cavalcanti AB; Davis-Karim A; Engen N; Denning E; Taylor Thompson B; Gelijns AC; Kan V; Davey VJ; Lundgren JD; Babiker AG; Neaton JD; Lane HC;
Lancet Respir Med; 2023 Sep; 11(9):791-803. PubMed ID: 37348524
[TBL] [Abstract][Full Text] [Related]
6. The Use of IV Vasoactive Intestinal Peptide (Aviptadil) in Patients With Critical COVID-19 Respiratory Failure: Results of a 60-Day Randomized Controlled Trial.
Youssef JG; Lavin P; Schoenfeld DA; Lee RA; Lenhardt R; Park DJ; Fernandez JP; Morganroth ML; Javitt JC; Jayaweera D
Crit Care Med; 2022 Nov; 50(11):1545-1554. PubMed ID: 36044317
[TBL] [Abstract][Full Text] [Related]
7. Repair of Acute Respiratory Distress Syndrome by Stromal Cell Administration in COVID-19 (REALIST-COVID-19): A structured summary of a study protocol for a randomised, controlled trial.
Gorman E; Shankar-Hari M; Hopkins P; Tunnicliffe WS; Perkins GD; Silversides J; McGuigan P; Jackson C; Boyle R; McFerran J; McDowell C; Campbell C; McFarland M; Smythe J; Thompson J; Williams B; Curley G; Laffey JG; Clarke M; O'Kane C; McAuley DF
Trials; 2020 Jun; 21(1):462. PubMed ID: 32493473
[TBL] [Abstract][Full Text] [Related]
8. Anticipated pharmacological role of Aviptadil on COVID-19.
Mukherjee T; Behl T; Sharma S; Sehgal A; Singh S; Sharma N; Mathew B; Kaur J; Kaur R; Das M; Aleya L; Bungau S
Environ Sci Pollut Res Int; 2022 Feb; 29(6):8109-8125. PubMed ID: 34846667
[TBL] [Abstract][Full Text] [Related]
9. The CHARTER-Ireland trial: can nebulised heparin reduce acute lung injury in patients with SARS-CoV-2 requiring advanced respiratory support in Ireland: a study protocol and statistical analysis plan for a randomised control trial.
Sheehan JR; Calpin P; Kernan M; Kelly C; Casey S; Murphy D; Alvarez-Iglesias A; Giacomini C; Cody C; Curley G; McGeary S; Hanley C; McNicholas B; van Haren F; Laffey JG; Cosgrave D
Trials; 2022 Sep; 23(1):774. PubMed ID: 36104785
[TBL] [Abstract][Full Text] [Related]
10. The INVENT COVID trial: a structured protocol for a randomized controlled trial investigating the efficacy and safety of intravenous imatinib mesylate (Impentri®) in subjects with acute respiratory distress syndrome induced by COVID-19.
Atmowihardjo L; Schippers JR; Bartelink IH; Bet PM; van Rein N; Purdy K; Cavalla D; Comberiati V; McElroy A; Snape SD; Bogaard HJ; Heunks L; Juffermans N; Schultz M; Tuinman PR; Bos LDJ; Aman J
Trials; 2022 Feb; 23(1):158. PubMed ID: 35172891
[TBL] [Abstract][Full Text] [Related]
11. Effect of early treatment with polyvalent immunoglobulin on acute respiratory distress syndrome associated with SARS-CoV-2 infections (ICAR trial): study protocol for a randomized controlled trial.
Mazeraud A; Gonçalves B; Aegerter P; Mancusi L; Rieu C; Bozza F; Sylla K; Siami S; Sharshar T
Trials; 2021 Feb; 22(1):170. PubMed ID: 33648563
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of dexamethasone treatment for patients with the acute respiratory distress syndrome caused by COVID-19: study protocol for a randomized controlled superiority trial.
Villar J; Añón JM; Ferrando C; Aguilar G; Muñoz T; Ferreres J; Ambrós A; Aldecoa C; Suárez-Sipmann F; Thorpe KE; Jüni P; Slutsky AS;
Trials; 2020 Aug; 21(1):717. PubMed ID: 32799933
[TBL] [Abstract][Full Text] [Related]
13. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
Akova M; Unal S
Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
[TBL] [Abstract][Full Text] [Related]
14. Effect of dexamethasone in patients with ARDS and COVID-19 (REMED trial)-study protocol for a prospective, multi-centre, open-label, parallel-group, randomized controlled trial.
Maláska J; Stašek J; Duška F; Balík M; Máca J; Hruda J; Vymazal T; Klementová O; Zatloukal J; Gabrhelík T; Novotný P; Demlová R; Kubátová J; Vinklerová J; Svobodník A; Kratochvíl M; Klučka J; Gál R; Singer M;
Trials; 2022 Jan; 23(1):35. PubMed ID: 35033182
[TBL] [Abstract][Full Text] [Related]
15. Open-label randomized controlled trial of ultra-low tidal ventilation without extracorporeal circulation in patients with COVID-19 pneumonia and moderate to severe ARDS: study protocol for the VT4COVID trial.
Richard JC; Yonis H; Bitker L; Roche S; Wallet F; Dupuis C; Serrier H; Argaud L; Thiery G; Delannoy B; Pommier C; Abraham P; Muller M; Aubrun F; Sigaud F; Rigault G; Joffredo E; Mezidi M; Terzi N; Rabilloud M
Trials; 2021 Oct; 22(1):692. PubMed ID: 34635128
[TBL] [Abstract][Full Text] [Related]
16. Flow controlled ventilation in Acute Respiratory Distress Syndrome associated with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Roehrig S; Ait Hssain A; Shallik NAH; Elsaid IMA; Mustafa SF; Smain OAM; Molokhia AA; Lance MD
Trials; 2020 Sep; 21(1):781. PubMed ID: 32917259
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic iloprost for the treatment of acute respiratory distress syndrome (ARDS) (the ThIlo trial): a prospective, randomized, multicenter phase II study.
Haeberle H; Prohaska S; Martus P; Straub A; Zarbock A; Marx G; Zago M; Giera M; Koeppen M; Rosenberger P
Trials; 2020 Mar; 21(1):242. PubMed ID: 32131881
[TBL] [Abstract][Full Text] [Related]
18. Sargramostim to treat patients with acute hypoxic respiratory failure due to COVID-19 (SARPAC): A structured summary of a study protocol for a randomised controlled trial.
Bosteels C; Maes B; Van Damme K; De Leeuw E; Declercq J; Delporte A; Demeyere B; Vermeersch S; Vuylsteke M; Willaert J; Bollé L; Vanbiervliet Y; Decuypere J; Libeer F; Vandecasteele S; Peene I; Lambrecht B
Trials; 2020 Jun; 21(1):491. PubMed ID: 32503663
[TBL] [Abstract][Full Text] [Related]
19. A prospective, randomised, double blind placebo-controlled trial to evaluate the efficacy and safety of tocilizumab in patients with severe COVID-19 pneumonia (TOC-COVID): A structured summary of a study protocol for a randomised controlled trial.
Rilinger J; Kern WV; Duerschmied D; Supady A; Bode C; Staudacher DL; Wengenmayer T
Trials; 2020 Jun; 21(1):470. PubMed ID: 32493514
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of hydroxychloroquine for post-exposure prophylaxis to prevent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among adults exposed to coronavirus disease (COVID-19): a structured summary of a study protocol for a randomised controlled trial.
Barnabas RV; Brown E; Bershteyn A; Miller RS; Wener M; Celum C; Wald A; Chu H; Wesche D; Baeten JM;
Trials; 2020 Jun; 21(1):475. PubMed ID: 32493478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
